Proteins were dispersed by SDS-PAGE and transferred to nitrocellulose membranes (Merck Millipore,
HATF00010). The membranes were blocked with 5% BSA at room temperature (RT) for 1 h and subsequently incubated with primary antibodies [
STAT5 (Santa Cruz, sc-1081), p-
STAT5 (Cell Signaling Technology, CST, 9314 s), HK1 (CST, 2024t), AKT (CST, 4685 s), p-AKT (CST, 4058 s), PFKP (CST, 8164t), PDHA (CST, 3205t),
β-actin (Santa Cruz, sc-47778), E3BP (Santa Cruz, sc-377255), Histone H3 (CST, 14269 s),
H3K18 lac (PTM Bio, PTM-1406RM),
H4K5 lac (PTM Bio, PTM-1409), H4K8 lac (PTM Bio, PTM-1415RM), H4K12 lac (PTM Bio, PTM-1411RM),
Pan-Kla (PTM Bio, PTM-1401RM) and
Flag-tag (ZenBio, 384091)]. After incubation of secondary antibodies, immunoreactive bands were monitored by the
chemiluminescent imaging system (Tanon Science & Technology).
Huang Z.W., Zhang X.N., Zhang L., Liu L.L., Zhang J.W., Sun Y.X., Xu J.Q., Liu Q, & Long Z.J. (2023). STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduction and Targeted Therapy, 8, 391.